Cardio-Pharm Exam Review: HTN, HF, Dyslipidemia, Arrhythmia & VTE (copy)

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/82

flashcard set

Earn XP

Description and Tags

78 Question-and-Answer flashcards summarizing diagnostic criteria, risk factors, pathophysiology, classifications, and treatments for hypertension, heart failure, dyslipidemia, arrhythmia, and VTE as presented in the lecture notes.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

83 Terms

1
New cards

What systolic and diastolic blood pressure values define hypertension per ACC/AHA 2017?

SBP ≥ 130 mmHg or DBP ≥ 80 mmHg

2
New cards

Why is hypertension often called the “silent killer”?

Because it is usually asymptomatic; persistently elevated BP may be the only physical finding.

3
New cards

How many elevated BP readings and encounters are required to diagnose hypertension?

At least two elevated readings at two separate clinical encounters.

4
New cards

Name four modifiable risk factors for hypertension.

Smoking, diabetes, dyslipidemia/ hypercholesterolemia, overweight/obesity (others: inactivity, unhealthy diet).

5
New cards

Give three relatively fixed (non-modifiable) hypertension risk factors.

Chronic kidney disease, family history, increasing age (others: male sex, low SES, OSA, psychosocial stress).

6
New cards

List three key non-pharmacologic interventions for primary hypertension prevention.

Weight management/DASH diet with sodium restriction, increased physical activity, smoking cessation.

7
New cards

Which four medication classes are first-line for uncomplicated hypertension?

Thiazide diuretics, ACE inhibitors, ARBs, calcium-channel blockers.

8
New cards

What is the recommended initial therapy for stage 1 HTN with ASCVD risk ≥ 10 %?

Non-pharm therapy plus one BP-lowering medication; reassess in 3–6 months.

9
New cards

How is stage 2 hypertension treated initially?

Lifestyle modification plus TWO antihypertensives from different classes; reassess monthly until goal reached.

10
New cards

Provide the formula for cardiac output.

CO = Heart Rate (HR) × Stroke Volume (SV).

11
New cards

According to Frank-Starling, how does increased preload affect stroke volume?

Increased sarcomere stretch → stronger contraction → increased stroke volume.

12
New cards

What is the most common etiology of HFrEF?

Coronary artery disease (myocardial infarction or ischemia).

13
New cards

Give two common causes of HFpEF.

Long-standing hypertension and increased ventricular stiffness (e.g., hypertrophic cardiomyopathy, amyloidosis).

14
New cards

List four major risk factors for developing heart failure.

Hypertension, coronary heart disease, diabetes, smoking (others: obesity, inactivity).

15
New cards

Define orthopnea.

Shortness of breath that occurs when lying flat; relieved by sitting or standing.

16
New cards

Which heart sound (extra gallop) is classically associated with heart failure?

An S3 gallop.

17
New cards

Describe NYHA Functional Class II.

Slight limitation of physical activity; comfortable at rest, ordinary activity causes symptoms.

18
New cards

What EF percentage defines HFrEF?

Left-ventricular ejection fraction ≤ 40 %.

19
New cards

What medication combination is core GDMT for Stage C HFrEF?

ARNI (or ACEi/ARB) + beta-blocker + MRA + SGLT2 inhibitor ± loop diuretic as needed.

20
New cards

When is hydralazine + isosorbide dinitrate specifically recommended in HFrEF?

For Black patients with persistent symptoms despite optimal therapy or those intolerant to ACEi/ARB/ARNI.

21
New cards

Which two drug classes should be avoided in LVEF < 50 %?

Thiazolidinediones (TZDs) and non-DHP calcium channel blockers (diltiazem/verapamil).

22
New cards

What lipid abnormality pattern defines hyperlipidemia?

Elevated total cholesterol, LDL, or triglycerides and/or low HDL.

23
New cards

Differentiate exogenous vs. endogenous cholesterol pathways.

Exogenous: dietary fats/cholesterol from gut to liver (post-prandial); Endogenous: cholesterol/triglycerides from liver to peripheral tissues and back (fasting state).

24
New cards

Name the four major plasma lipoprotein classes.

Chylomicrons, VLDL, IDL, LDL (plus HDL).

25
New cards

What are the four letters in VTE risk factor Virchow’s Triad?

Blood stasis, vascular injury, hypercoagulability (no fourth—triad).

26
New cards

Give two clinical signs of proximal DVT.

Unilateral leg swelling and pain/tenderness (plus warmth, redness, palpable cord).

27
New cards

Which imaging modality is gold standard for DVT diagnosis?

Contrast venography (invasive).

28
New cards

How many Wells Score points classify a DVT as unlikely?

0 points.

29
New cards

What lab finding supports VTE diagnosis but is nonspecific?

Elevated D-dimer (fibrin degradation product).

30
New cards

Define massive PE.

PE causing hemodynamic instability, cardiac or respiratory arrest, or acute right-ventricular failure.

31
New cards

State the minimum anticoagulation duration after an initial VTE event.

At least 3 months for all patients.

32
New cards

Name three non-pharmacologic VTE prevention devices.

Graduated compression stockings (GCS), intermittent pneumatic compression (IPC), sequential compression devices (SCD).

33
New cards

What is the mechanism of action of alteplase in massive PE?

Converts plasminogen to plasmin, dissolving fibrin clots and restoring perfusion.

34
New cards

Provide the standard alteplase dose for PE.

100 mg IV infused over 2 hours.

35
New cards

Which adverse drug reaction is most concerning with unfractionated heparin?

Heparin-induced thrombocytopenia (HIT).

36
New cards

List prophylactic dosing for enoxaparin in normal renal function.

40 mg SQ once daily or 30 mg SQ every 12 h.

37
New cards

What anti-Xa level monitoring situations might be needed for LMWH?

Pregnancy, obesity, low body weight, pediatrics, or renal insufficiency.

38
New cards

Which parenteral anticoagulant is preferred in patients with HIT?

Argatroban (direct thrombin inhibitor).

39
New cards

How does fondaparinux differ mechanistically from LMWH?

It selectively inhibits factor Xa only (no direct thrombin inhibition).

40
New cards

State a contraindication to fondaparinux use.

CrCl < 30 mL/min (or active major bleeding, bacterial endocarditis).

41
New cards

Name three oral factor Xa inhibitors.

Rivaroxaban, apixaban, edoxaban (also betrixaban).

42
New cards

What black-box warning is shared by all DOACs regarding neuraxial anesthesia?

Risk of spinal/epidural hematoma leading to paralysis.

43
New cards

Which antidote reverses rivaroxaban or apixaban overdose?

Andexanet alfa (Andexxa).

44
New cards

What is the mechanism of dabigatran?

Direct, reversible inhibition of thrombin (factor IIa).

45
New cards

Which clotting factors are depleted by warfarin therapy?

Factors II, VII, IX, X and proteins C & S.

46
New cards

What is the typical INR goal for most warfarin indications?

INR 2.0-3.0.

47
New cards

How long must parenteral anticoagulation overlap with warfarin when bridging?

At least 5 days AND until two therapeutic INRs ≥ 24 h apart.

48
New cards

List four common drug classes that raise bleeding risk when combined with warfarin.

NSAIDs, antiplatelets, other anticoagulants, SSRIs/SNRIs.

49
New cards

What genetic or acquired condition creates a hypercoagulable state and increases VTE risk?

Factor V Leiden mutation (others: antiphospholipid antibodies, protein C/S deficiency).

50
New cards

Which points on Simplified Wells Score assign 3 points each?

Clinical sign of DVT and PE more likely than alternate diagnosis.

51
New cards

State one classic metabolic cause of arrhythmias remembered by the acronym “MEDS.”

Metabolic derangements (others: Electrolyte disturbances, Drug toxicity, Structural abnormalities).

52
New cards

Name three reversible risk factors for atrial fibrillation.

Excess alcohol (withdrawal or binge), surgery, thyrotoxicosis (others: hypertension, intense exercise).

53
New cards

Why are anticoagulants central in atrial fibrillation management?

To prevent cardioembolic stroke resulting from atrial thrombus formation.

54
New cards

What is the goal of secondary hypertension prevention?

Prevent recurrent cardiovascular events (<10 % of HTN cases).

55
New cards

Which diet is specifically recommended for BP lowering?

DASH diet (Dietary Approaches to Stop Hypertension).

56
New cards

How does potassium intake influence blood pressure?

Higher dietary potassium can blunt sodium’s pressor effect, aiding BP reduction.

57
New cards

Name one beta-blocker proven to reduce mortality in HFrEF.

Carvedilol (others: metoprolol succinate, bisoprolol).

58
New cards

What SGLT2 inhibitors have HF outcome data?

Dapagliflozin and empagliflozin.

59
New cards

Define HFimpEF.

Initial LVEF ≤ 40 % with follow-up EF ≥ 50 % after therapy; continue GDMT to avoid relapse.

60
New cards

Which HF stage includes patients with structural heart disease but no symptoms?

Stage B (pre-HF).

61
New cards

What blood test helps identify congestion in heart failure but is not in notes?

Brain natriuretic peptide (BNP) or NT-proBNP.

62
New cards

Which lifestyle modification can improve both blood pressure and dyslipidemia?

Regular aerobic physical activity/exercise.

63
New cards

What is the primary prevention statin recommendation age per USPSTF 2022 (brief)?

Adults 40-75 with ≥ 1 CVD risk factor and 10-year risk ≥ 10 % (detailed algorithm beyond scope).

64
New cards

Explain why UFH requires a continuous IV infusion for VTE treatment.

It has a short half-life (30–90 min) and variable pharmacokinetics requiring steady plasma levels.

65
New cards

List two serious complications specifically associated with warfarin early therapy.

Skin necrosis/gangrene and purple toe syndrome.

66
New cards

Why must 15 mg and 20 mg rivaroxaban tablets be taken with food?

Food increases absorption and bioavailability at higher doses.

67
New cards

Describe the monitoring needed for DOAC efficacy.

Routine efficacy labs are unnecessary; monitor Hgb/Hct, SCr annually or if bleeding suspected.

68
New cards

Which heart failure medication stimulates soluble guanylate cyclase?

Vericiguat (for worsening symptomatic HFrEF).

69
New cards

Give one contraindication to alteplase use.

Active internal bleeding (others: recent stroke within 2 months, severe uncontrolled HTN).

70
New cards

How does obesity increase VTE risk via Virchow’s Triad?

It promotes venous stasis and hypercoagulability due to increased inflammatory mediators.

71
New cards

State the prophylactic fondaparinux dose for patients ≥ 50 kg.

2.5 mg SQ once daily (5–9 days, extend up to 35 days post-surgery).

72
New cards

Which laboratory value is falsely elevated by argatroban, complicating warfarin overlap?

INR (prothrombin time).

73
New cards

What are two key side effects of LMWH besides bleeding?

Thrombocytopenia and hyperkalemia (also ↑LFTs).

74
New cards

Outline the initial weight-based UFH bolus for VTE treatment.

80 units/kg IV bolus followed by 18 units/kg/hr infusion.

75
New cards

Explain the rationale for not expelling the air bubble from prefilled enoxaparin syringes.

The air bubble ensures complete drug delivery and prevents drug tracking into subcutaneous tissue.

76
New cards

What patient group is at highest risk for drug-induced dilated cardiomyopathy leading to HFrEF?

Patients receiving cardiotoxic chemotherapy (e.g., anthracyclines) or chronic alcohol abuse.

77
New cards

Which two parameters must be met before stopping bridging anticoagulation to warfarin?

At least 5 days of overlap and two consecutive therapeutic INRs ≥ 24 h apart.

78
New cards

What is the renal adjustment for enoxaparin treatment when CrCl < 30 mL/min?

1 mg/kg SQ once daily (instead of twice daily).

79
New cards

Identify the four forces that constitute ventricular afterload.

Ejection impedance, wall tension, regional wall geometry, systemic vascular resistance.

80
New cards

Which heart failure symptom specifically occurs when bending forward?

Bendopnea.

81
New cards

Name one psychosocial factor that can increase blood pressure.

Chronic stress (including job, financial, or social stressors).

82
New cards

Why are non-DHP CCBs avoided in HFrEF?

They have negative inotropic effects that can worsen systolic dysfunction.

83
New cards

List two algorithms/scores used to stratify PE probability.

Wells Score and Simplified Wells Score (also Geneva not in notes).